Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01000870 · ClinicalTrials.gov registry record · Early Phase 1

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

A Early Phase 1 study, sponsored by Institute for Neurodegenerative Disorders.

Terminated
Registry status
Early Phase 1
Development phase
6
Enrollment target

NCT01000870: Clinical Trial Early Phase 1 study, sponsored by Institute for Neurodegenerative Disorders.

NCT01000870 is a Early Phase 1 study that was terminated before completion, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 6 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01000870, a Early Phase 1 study, was terminated before completion, sponsored by Institute for Neurodegenerative Disorders.

TERMINATED
Registry status
Early Phase 1
Development phase
6 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the efficacy and safety of MNI-513 positron emission tomography (PET) for detection/exclusion of cerebral amyloid beta in patients with Alzheimer's disease compared to healthy volunteers.

Interventions

  • DRUG MNI-513-01

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2009-10
Est. Completion 2010-09
Phase Early Phase 1

Why NCT01000870 stopped before completion

NCT01000870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which MNI-513-01 is the first listed.

NCT01000870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01000870 about?

NCT01000870 is a clinical study titled "Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513". The purpose of the study is to evaluate the efficacy and safety of MNI-513 positron emission tomography (PET) for detection/exclusion of cerebral amyloid beta in patients with Alzheimer's disease compared to healthy volunteers.

What is the current status of trial NCT01000870?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2009-10. Estimated completion is 2010-09.

What interventions are being tested in trial NCT01000870?

The interventions under investigation include: MNI-513-01 (DRUG).

Who is sponsoring clinical trial NCT01000870?

This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01000870's enrollment target sits among peer trials

6 1845th of 2000 higher than 114 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01000870, the US trial registry maintained by the National Library of Medicine. NCT01000870 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.